Three treatment methods via the hepatic artery for hepatocellular carcinoma-a retrospective study

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2491-2494

  Ma, Teng Chuang ^a   Shao, Hai Bo ^a   Xu, Yang ^a   Xu, Ke ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Effect; HCC; Hepatic artery; Intervention treatment; Retrospective

Indexed keywords

EID: 84880264809     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2491     Document Type: Article

References (15)

1. Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. Hepatol J, 35, 421-30.
2. Cammà C, Schepis F, Orlando A, et al (2002). Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology J, 224, 47-54.
3. Farinati F, Giacomin A, Vanin V, et al (2012). TACE treatment in hepatocellular carcinoma: what should we do now. Hepatol J, 57, 221-2.
4. Forner A, Llovet JM, Bruix J (2012). Chemoembolization intermediate HCC: is there proof of survival benefit. Hepatol J, 56, 984-6.
5. Geschwind JF, Ramsey DE, Choti MA, et al (1988). Chemoembolization of hepatocellular carcinoma: results of a metaanalysis. Clin Oncol AM J, 26, 344-9.
6. Ikoma A, Kawai N, Sato M, et al (2012). Comparison of blood dynamics of anticancer drugs (cisplatin, mitomycin C, epirubicin) in treatment groups of hepatic arterial infusion, hepatic arterial infusion with lipiodol and transcatheter arterial chemoembolization with lipiodol plus gelatin sponge particles in a swine model. Hepatol Res J, 42, 1227-35.
7. Izumi R, Urade M, Kimura H, et al (1988). Combined hepatic arterial infusion chemotherapy with transcatheter arterial embolization and hyperthermia in primary liver cancer. Gan To Kagaku Ryoho, 15, 2465-9.
8. Lencioni R (2012). Chemoembolization for hepatocellular carcinoma. Semin Oncol J, 39, 503-9.
9. Llovet JM, Bruix J (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology J, 37, 429-42.
10. Marelli L, Stigliano R, Triantos C, et al (2007). Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol J, 30, 6-25.
11. Miraglia R, Pietrosi G, Maruzzelli L, et al (2007). Efficacy of transcatheter emoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol J, 13, 2952-5.
12. Morse MA, Hanks BA, Suhocki P, et al (2012). Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. Clin Colorectal Cancer J, 11, 185-90.
13. Oliveri RS, Wetterslev J, Gluud C (2011). Transarterial (chemo) embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev, 16, CD004787.
14. Pleguezuelo M, Marelli L, Misseri M, et al (2008). TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther, 8, 1623-41.
15. Takayama W, Asano T, Kobayashi S, et al (1998). Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE). Gan To Kagaku Ryoho, 25, 867-71.